Diabetes
Showing NaN - NaN of 73
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- basal insulin
-
Birmingham, Alabama
- +57 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +85 more
May 28, 2019
Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes Trial in Worldwide (ALN-PCSSC, Normal Saline)
Completed
- Atherosclerotic Cardiovascular Disease
- +2 more
- ALN-PCSSC
- Normal Saline
-
Jacksonville, Florida
- +53 more
Apr 23, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +108 more
Dec 7, 2018
Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Birmingham, Alabama
- +98 more
Dec 7, 2018
Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
- +2 more
-
Birmingham, Alabama
- +95 more
Sep 3, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +301 more
Feb 16, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Anaheim, California
- +131 more
Aug 25, 2017
Obesity, Diabetes, Hypertension Trial in Birmingham (Exercise, Reduced Calorie Diet, Weight Maintenance Diet)
Completed
- Obesity
- +3 more
- Exercise
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 1, 2017
Diabetes, Pre-hypertension, Hypertension Trial in Birmingham (aliskiren 300 mg once daily, Placebo/sugar pill)
Terminated
- Diabetes
- +2 more
- aliskiren 300 mg once daily
- Placebo/sugar pill
-
Birmingham, AlabamaUAB
Apr 5, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Dietary regimen)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin detemir
- Dietary regimen
-
Birmingham, Alabama
- +111 more
Mar 28, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Alexander City, Alabama
- +135 more
Mar 8, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Birmingham, Alabama
- +90 more
Mar 8, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin NPH, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin detemir
- +2 more
-
Pleven, Bulgaria
- +42 more
Jan 30, 2017
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, NPH insulin, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin detemir
- +2 more
-
Buenos Aires, Argentina
- +99 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Ireland, United Kingdom (biphasic insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +2 more
-
Dublin, Ireland
- +62 more
Jan 26, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Birmingham, Alabama
- +125 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Birmingham, Alabama
- +165 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, insulin detemir, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Alexander City, Alabama
- +232 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
-
Birmingham, Alabama
- +44 more
Jan 20, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +104 more
Jan 20, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Northridge, California
- +98 more
Jan 20, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (rosiglitazone, inhaled human insulin, metformin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +2 more
-
Ebreichsdorf, Austria
- +73 more
Feb 28, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin aspart
- insulin detemir
-
Birmingham, Alabama
- +66 more
Jan 2, 2017